Pasar al contenido principal

DESARROLLO DE NUEVOS NANOBIOMATERIALES INTELIGENTES PARA APLICACIONES BIOMEDICAS: EVALUACION FUNCIONAL MEDIANTE ESTRATEGIAS BIOANALITICAS Y ANALISIS MULTI-OMICO

PID2023-150182OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD COMPLUTENSE DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

Silver-selenium hybrid nanocomposite with combined cytotoxic and metabolic reprogramming effects in triple-negative breast cancer

  • Buendia Nacarino, M. Pilar
  • Álvarez-Fernández García, Roberto
  • Martínez López, Angélica
  • Castillo Lluva, Sonia
  • González Ortiz, Blanca
  • Luque García, José Luis
Triple-negative breast cancer (TNBC) remains one of the most aggressive breast cancer subtypes due to its high metastatic potential, poor response to conventional therapies, and frequent relapse after chemotherapy. In this work, we report a novel hybrid nanosystem that integrates, within a single mesoporous silica nanoplatform, two inorganic nanoparticles with complementary antitumoral activities: silver nanoparticles confined inside a mesoporous silica shell and selenium nanoparticles nucleated on the external surface. The core@shell Ag@MSN nanosystem was functionalized with transferrin to guide selective uptake by cancer cells which moreover provides the protein matrix required for controlled selenium nanoparticle growth, yielding the final Ag@MSN-Tf-SeNPs nanocomposite. The nanosystem was thoroughly physicochemically characterized and biologically evaluated in MDA-MB-231 TNBC cells. Ag@MSN-Tf-SeNPs showed efficient and selective internalization mediated by transferrin receptors and displayed a markedly enhanced cytotoxic effect resulting from the combined action of Ag and Se. Cell-cycle analysis revealed G0/G1 arrest accompanied by a strong induction of apoptosis. To unravel the underlying bioactivities, an untargeted mass spectrometry-based metabolomics assay demonstrated profound metabolic disruption, including altered fatty-acid metabolism, impaired TCA cycle activity, and suppression of key biosynthetic pathways essential for TNBC survival. Finally, the antitumoral efficacy of the nanosystem was validated in vivo using a chicken chorioallantoic membrane model, where Ag@MSN-Tf-SeNPs significantly reduced tumor mass. Overall, this study presents a novel Ag–Se hybrid silica nanocomposite with selective tumor cells targeting, combined mechanisms of action, and potent antitumoral activity, highlighting its promise as a therapeutic platform for TNBC.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Biopolymer-stabilized selenium and selenium‑copper nanoparticles with antioxidant and photoprotective dual functionality

  • Luque García, José Luis
  • Anunciacao, Daniela S.
  • Barbosa, Cintya D. Angeles do E.S.
  • Carinhanha, Josue
  • Guimaraes, Ari S.
  • Oliveria, Woodland de S.
  • Perez Roldan, Angel
  • da Silva Neta, Maria de Fatima
  • da Vega, Amanda G.
The development of multifunctional nanomaterials with antioxidant and photoprotective properties offers significant potential for cosmetic and biomedical applications. In this study, selenium (SeNPs) and selenium–copper (SeCuNPs) nanoparticles were synthesized via chemical reduction using chitosan (CHI) and polyvinyl alcohol (PVA) as stabilizers. Transmission electron microscopy confirmed a spherical morphology, with mean sizes of 85.4 ± 20.2 nm (SeNPs_CHI) and 76.2 ± 12.0 nm (SeCuNPs_CHI), and significantly smaller sizes for PVA-stabilized formulations (34.3 ± 4.0 nm and 32.5 ± 5.8 nm, respectively). X-ray photoelectron spectroscopy (XPS) confirmed the presence of elemental selenium (Se0) and copper (Cu0) in the hybrid nanoparticles. All formulations exhibited potent antioxidant capacity, as demonstrated by ABTS●+, DPPH●, and FRAP assays, outperforming classical standards including Trolox®, ascorbic acid, and quercetin. In vitro sun protection factor (SPF) values were significantly higher than that of the commercial UV filter 2-hydroxy-4-methoxybenzophenone (BZF-3), particularly for SeCuNPs_PVA. Additionally, the nanoparticles displayed excellent photostability under simulated solar irradiation, maintaining or improving SPF over time. These findings highlight the potential of selenium-based nanoparticles, especially hybrid SeCuNPs, as multifunctional agents with strong antioxidant and photoprotective activity, offering a promising platform for the development of next-generation dermocosmetic and biotechnological products.
Docta Complutense
Publicación Artículo científico (JournalArticle)

A third-generation rhodium-based nanophotosensitizer for precision photodynamic cancer therapy

  • Machuca Marcos, Andrés
  • Álvarez-Fernández García, Roberto
  • Aragoneses Cazorla, Guillermo
  • Castillo Lluva, Sonia
  • Vallet Regí, María Dulce Nombre
  • González Ortiz, Blanca
  • García Calvo, Estefanía
  • Luque García, José Luis
Rhodium-based nanocomposites represent an unexplored class of functional materials with potential in biomedicine. Here, we present RhNPs-MSNs-Tf, a third-generation nanophotosensitizer composed of rhodium nanoparticles (RhNPs) confined within mesoporous silica nanoparticles (MSNs) and surface-modified with transferrin (Tf) to enable receptor-mediated tumor targeting. This represents the first silica-based nanocomposite integrating RhNPs for biomedical applications ever reported in literature. The hybrid structure is obtained through a robust multistep synthetic route and extensively characterized, confirming uniform RhNPs incorporation, preserved mesoporosity, colloidal stability and excellent biocompatibility. Under near-infrared (NIR) irradiation, RhNPs-MSNs-Tf efficiently generates singlet oxygen (1O2). Cellular studies demonstrate selective stress and energy metabolism pathways as underlying mechanisms. In vivo evaluation using the chicken chorioallantoic membrane (CAM) model shows significant tumor growth inhibition without apparent systemic toxicity. By combining structural precision, efficient photodynamic response and active targeting capability, RhNPs-MSNs-Tf establishes a versatile, light-activated nanoplatform. These findings highlight the promise of rhodium-based nanocomposites as next-generation functional materials for tumor-selective photodynamic therapy (PDT).